Larimar Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Larimar Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2024.
  • Larimar Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $2.41M, a 25.6% increase year-over-year.
  • Larimar Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $8.8M, a 15.5% increase year-over-year.
  • Larimar Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $8.8M, a 15.5% increase from 2023.
  • Larimar Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.62M, a 15% increase from 2022.
  • Larimar Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.62M, a 20.9% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $8.8M +$1.18M +15.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 $7.62M +$996K +15% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 $6.62M +$1.15M +20.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $5.47M +$3.31M +153% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $2.16M +$2.03M +1575% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
2019 $129K -$9.5M -98.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 $9.63M +$1.33M +16% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $8.3M -$1.63M -16.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
2016 $9.93M +$1.35M +15.7% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $8.58M +$7.03M +453% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
2014 $1.55M +$1.16M +293% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
2013 $395K +$274K +226% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $121K Jan 1, 2012 Dec 31, 2012 10-K 2015-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.